Kyle Ockerman

10 papers receiving 196 citations

Kyle Ockerman's Hit Papers

Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis 2023 · 104 citations
1040+1+2Years since publication255075100

Peers

Kyle Ockerman
Comparison fields: 5 of 52
  • Aging 5
  • Endocrinology, Diabetes and Metabolism 41
  • Pharmacy 8
  • Pharmacology 22
  • Immunology 27
Replace Anna‐Karin Lind with:
Anna‐Karin Lind Sweden
Anne Katerine Omland Norway
Loes M E Moolhuijsen Netherlands
Emil Andersen Denmark
Ali Aflatounian Australia
Karen Inglis Canada
Sam Sollie United Kingdom
Maryam Kianpour Iran
J Łopatyński Poland
Patrik Šimják Czechia
Kyle Ockerman relative to Anna‐Karin Lind Sweden Anna‐Karin Lind's profile →
Citations per field
00.5×10×14×
Anna‐Karin Lind · 1×
Citations per year

Countries citing papers authored by Kyle Ockerman

Since Specialization
Citations

This map shows the geographic impact of Kyle Ockerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Ockerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Ockerman more than expected).

Fields of papers citing papers by Kyle Ockerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Ockerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Ockerman. The network helps show where Kyle Ockerman may publish in the future.

Co-authors

The 25 scholars most cited alongside Kyle Ockerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kyle Ockerman Line = papers co-authored together Kyle Ockerman links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Public Interest in the Off-Label Use of Glucagon-like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis
Hit paper breakdown →
2023104
2 202153
3 202321
4 202010
5 20235
6 20244
7 20252
8 20242
9 20241
10 20231
11 20220
12 20230
13 20240
14 20240

About Kyle Ockerman

Kyle Ockerman is a scholar working on Oncology, Surgery, Molecular Biology, Social Psychology and Neurology, having authored 14 papers that have together received 203 indexed citations. Recurring topics across this work include Healthcare professionals’ stress and burnout (1 paper), BRCA gene mutations in cancer (1 paper), COVID-19 and healthcare impacts (1 paper), Hemostasis and retained surgical items (1 paper), Cancer survivorship and care (1 paper), Botulinum Toxin and Related Neurological Disorders (1 paper), Lipid metabolism and biosynthesis (1 paper) and LGBTQ Health, Identity, and Policy (1 paper). The work is most often cited by research in Aging (5 citations), Endocrinology, Diabetes and Metabolism (41 citations), Pharmacy (8 citations), Pharmacology (22 citations) and Immunology (27 citations). Kyle Ockerman has collaborated with scholars based in United States and China. Frequent co-authors include Heather Furnas, Patricia Mars, Peter P. Du, W. Nicholas Haining, Kathleen B. Yates, Arash Momeni, Sarah Kate Lane-Reticker, Emily Kessler, Clara Wolfe and Hans W. Pope. Their work appears in journals such as Aesthetic Surgery Journal, International Journal of Transgender Health, PLoS Biology, Journal of the American College of Surgeons and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact